D-chiro-inositol and Endometrial Thickness

Not Applicable

Completed

• Conditions: Endometrial Diseases
• Interventions: Dietary Supplement: DCI

• Registration Number: NCT05283642
• Lead Sponsor: Lo.Li.Pharma s.r.l

Brief Summary

Investigation of the effects of D-chiro-inositol supplementation in women with altered endometrial thickness.

Detailed Description

Not available

Study Timeline

• Status Verified: 2022-03
• Study Start: 2022-03-08
• Study First Submitted: 2022-03-08
• Study First Submitted QC: 2022-03-16
• Study First Posted: 2022-03-17
• Primary Completion: 2022-10-29
• Study Completion: 2022-12-20
• Last Update Submitted: 2022-12-22
• Last Update Posted: 2022-12-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 13

Inclusion Criteria

• altered endometrial thickness

Exclusion Criteria

• patients with cancer
• patients under hormonal treatments (progestogens and/or estrogens)
• patients supplemented with inositols

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
DCI	DCI	Oral supplementation with D-chiro-inositol once a day

Primary Outcome Measures

Name	Time	Method
Change in endometrial thickness	Two time points: baseline and after three months	Change in endometrial thickness by ultrasound measurement from baseline to three months

Trial Locations

Locations (1)

ASL Umbria 2; 🇮🇹 Terni, Umbria, Italy